Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes.
Dimitrios NasioudisNayla LabbanNawar LatifStefan GyslerLori CorySarah KimRobert L GiuntoliEmily M KoPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
In this study approximately one in four patients received adjuvant immunotherapy. Immunotherapy was not associated with improved overall survival.